Past Events

The 2015 Vaccine Summit: 13th – 15th October 2015



This event has now past, please view for a list of our current events

Talks Included:

  • Effect of oil adjuvants on integrity of foot-and-mouth disease virus vaccine antigens:  

Dr. Michiel M. Harmsen, Scientist, Central Veterinary Institute Wageningen UR, Division Virology, Lelystad, The Netherlands

  • Therapuetic use of vaccine for treatment of chronic hepatitis B: from bench to bedside:  

Dr. Sheikh Mohamad Fazle Akbar, MBBS, MD, PhD, Principal Investigator, Toshiba General Hospital, Tokyo, Japan

  • Approaches for inducing an immune response against tumor antigens:  

Dr Jonathan Lewis, Boston, United States

  • Integration of biology and mathematical modelling towards a better understanding of pathogen behaviour and rational design of improved bacterial vaccines:

Dr Piero Mastroeni, Reader in Infection and Immunity, University of Cambridge, United Kingdom

  • Oncolytic activity of attenuated Measles virus against mesothelioma:

 Dr Jean-François FONTENEAU, Chargé de recherche INSERM, INSERM UMR892, CNRS UMR6299, Institut de Recherche en Santé de l’Université de Nantes, France

  • Oral vaccines for the control of poultry diseases:  

Professor Anthony Amaechi ATTAMA, Department of Pharmaceutics, University of Nigeria, Nsukka, Nigeria

  • Investigation of antibodies generated in response to vaccination with a HCMV gB subunit vaccine:  

Dr Gary R McLean, Imperial College London & London Metropolitan University, London, UK

  • Why do parents who usually vaccinate their children hesitate or refuse General good vs. individual risk:  

Dr Anat Gesser-Edelsburg, Head of Health Promotion Department, School of Public Health, University of Haifa, Israel

  • HIV-1 Vaccines: The Yin and Yang of Viral Entry Where We Keep Getting It Wrong:  

Dr Cynthia L. Bristow, Chief Executive Officer, Alpha-1 Biologics, New York, USA

  • Plant-derived vaccines:  

Dr Athleen Hefferon, University of Toronto, Ont., Canada

  • Patient Safety: Using technology to select the  right vaccine, right person, right schedule: 

Dr Adrienne Willcox, Health Team Ltd., Glos, UK

  • Russian vaccines against especially dangerous bacterial pathogens:  

Dr Valentina A Feodorova, Saratov, Russia

  • Overview of assays for influenza vaccines immunology evaluation and correlates of protection:  

Professor Emanuele Montomoli, Dept. of Molecular and Developmental Medicine, University of Siena, Italy

  • Evolutionary Therapy: Immunotherapy As Personalized Medicine:  

Dr Ravi A. Madan, Clinical Director, Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, USA

  • Factors Influencing the Recommendation of the Human Papillomavirus Vaccine by South African Doctors:  

Dr Muhammad Hoque, University of KwaZulu-Natal (Westville Campus), Durban, South Africa

  • Realising the Potential of Viral Vectored Vaccines:  

Dr. Sarah Gilbert, University of Oxford, Jenner Insitute, Oxford, United Kingdom

  • Sublingual vaccination and vaccine delivery systems:  

Jaroslav Turánek, Head of Department of Immunology and Immunotherapy, Veterinary Research Institute, Czech Republic

  • State of the art of VLP-based vaccines against influenza virus- commercial and scientific approach:

Dr Beata Gromadzka. Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk, Medical University of Gdansk, Poland

  • Development of a Lentivirus-Based Reference Material for Zaire Ebola Virus Nucleic Acid Amplification Assays.

Dr. Giada Mattiuzzo, NIBSC, Potters Bar, UK

  • Reference materials and standards for serological assays in vaccine evaluation

Dr Mark Page, NIBSC, Potters Bar, UK

  • Designing new vaccines to safeguard global poliovirus eradication:

Dr Andrew Macadam, NIBSC, Herts, United Kingdom

  • Clostridium difficile Vaccine- C diffense Study:

Dr Amit Arora, Consultant physician and Geriatrician, University Hospital of North Midlands, Stoke on Trent, United Kingdom

  • Aβ immunotherapy with single chain variable fragments for Alzheimer’s disease:

Dr Sandra Villegas, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain

  • New data for Vaccination for Pneumococcus

Assistant Professor Paraskevi A. Katsaounou, Medical School University of Athens, Evangelismos Hospital, Athens, Greece




Email:? enquiries [@]

Phone:?(+44) 020 3807 3712

Abstract and Poster Presentations

All abstracts accepted for oral presentation are also automatically accepted for poster presentation


Cancellation Policy

Join the conversation

Related past events




This is a closed event

Only participants who have registered are licensed to attend this event. This is for the protection and peace of mind of our speakers who are presenting unpublished work. We ask our participants not to share their screen with people who are not registered for the event and will fine those who do.

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: